Login / Signup

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.

Merete Lund HetlandEspen A HaavardsholmAnna RudinDan NordströmMichael NurmohamedBjorn GudbjornssonJon LampaKim Hørslev-PetersenTill UhligGerdur GrondalMikkel ØstergaardMarte S HeibergJos TwiskKristina LendSimon KrabbeLise Hejl HyldstrupJoakim LindqvistAnna-Karin Hultgård EkwallKathrine Lederballe GrønMeliha KapetanovicFrancesca FaustiniRiitta TuompoTove LorenzenGiovanni CagnottoEva BaecklundOliver HendricksDaisy VedderTuulikki Sokka-IslerTomas HusmarkMaud-Kristine Aga LjosåEli BrodinTorkell EllingsenAnnika SöderberghMilad RizkÅsa Reckner OlssonPer LarssonLine UhrenholtSøren Andreas JustDavid John StevensTrine Bay LaurbergGunnstein BaklandInge C OlsenRonald van Vollenhovennull null
Published in: BMJ (Clinical research ed.) (2020)
EudraCT2011-004720-35, NCT01491815.
Keyphrases
  • clinical trial
  • rheumatoid arthritis
  • study protocol
  • open label
  • double blind
  • placebo controlled
  • phase ii
  • phase iii
  • systemic sclerosis
  • interstitial lung disease
  • combination therapy
  • replacement therapy